Abstract
BackgroundWarfarin has been the anticoagulant of choice for the prevention of ischaemic stroke in patients with atrial fibrillation (AF). Novel oral anticoagulants (NOACs) are increasingly used as an alternative.ObjectivesThe objective...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have